Clinical Trial Update: Donepezil in the Prevention of Post-Operative Cognitive Decline [Phase 4]

View source ↗

Summary

A Phase 4 study sponsored by Pfizer evaluated whether donepezil can prevent postoperative cognitive decline and delirium; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Cognitive Dysfunction
• Postoperative Delirium

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Pfizer | Conditions: Postoperative Complications, Delirium | Phase 4 | Status: COMPLETED